SAGARD NEWGEN PHARMA

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: FRLegal Form: MQU9

ACTIVE

LEI: 969500JM0Y7TIQ5BPU81

Summary

SAGARD NEWGEN PHARMA is an organization. It is a subsidiary of SAGARD SAS.

Legal entity: GLEIF